In vivo functional analyses of the type II acyl carrier proteins of fatty acid biosynthesis.
Acyl carrier protein (ACP) is a key component of the fatty acid synthesis pathways of both type I and type II synthesis systems. A large number of structure-function studies of various type II ACPs have been reported, but all are in vitro studies that assayed function or interaction of mutant ACPs with various enzymes of fatty acid synthesis or transfer. Hence in these studies functional properties of various mutant ACPs were assayed with only a subset of the many ACP-interacting proteins, which may not give an accurate overall view of the function of these proteins in vivo. This is especially so because Escherichia coli ACP has been reported to interact with several proteins that have no known roles in lipid metabolism. We therefore tested a large number of mutant derivatives of E. coli ACP carrying single amino acid substitutions for their abilities to restore growth to an E. coli strain carrying a temperature-sensitive mutation in acpP, the gene that encodes ACP. Many of these mutant proteins had previously been tested in vitro thus providing data for comparison with our results. We found that several mutant ACPs containing substitutions of ACP residues reported previously to be required for ACP function in vitro support normal growth of the acpP mutant strain. However, several mutant proteins reported to be severely defective in vitro failed to support growth of the acpP strain in vivo (or supported only weak growth). A collection of ACPs from diverse bacteria and from three eukaryotic organelles was also tested. All of the bacterial ACPs tested restored growth to the E. coli acpP mutant strain except those from two related bacteria, Enterococcus faecalis and Lactococcus lactis. Only one of the three eukaryotic organellar ACPs allowed growth. Strikingly the ACP is that of the apicoplast of Plasmodium falciparum (the protozoan that causes malaria). The fact that an ACP from a such diverse organism can replace AcpP function in E. coli suggests that some of the protein-protein interactions detected for AcpP may be not be essential for growth of E. coli.
De Lay
Nicholas R
NR
Department of Microbiology, University of Illinois at Urbana-Champaign, 601 S. Goodwin Avenue, Urbana, IL 61801, USA.
Cronan
John E
JE
D000213:Acyl Carrier Protein / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D001059:Apoproteins / Q000235:genetics / Q000378:metabolism*; D013293:Enterococcus faecalis / Q000235:genetics; D048168:Escherichia coli K12 / Q000235:genetics / Q000254:growth & development / Q000378:metabolism*; D029968:Escherichia coli Proteins / Q000235:genetics / Q000378:metabolism*; D054889:Fatty Acid Synthase, Type II; D005227:Fatty Acids / Q000096:biosynthesis* / Q000235:genetics; D005816:Genetic Complementation Test; D013294:Lactococcus lactis / Q000235:genetics; D050356:Lipid Metabolism / Q000502:physiology*; D015388:Organelles / Q000235:genetics; D010963:Plasmodium falciparum / Q000235:genetics; D015800:Protozoan Proteins / Q000235:genetics / Q000378:metabolism
D000213:Acyl Carrier Protein; D001059:Apoproteins; D029968:Escherichia coli Proteins; D005227:Fatty Acids; D015800:Protozoan Proteins; C040157:acpP protein, E coli; D054889:Fatty Acid Synthase, Type II